Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 8/20 | 0.42 |
| ▸ | CTSK | P43235 | 8/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.38 |
| ▸ | REN | P00797 | 6/20 | 0.36 |
| ▸ | CTSL | P07711 | 2/20 | 0.35 |
| ▸ | CTSB | P07858 | 2/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8893431 | 1.00 | CTSS (0.42) | CTSSCTSKSCN9ARENCTSL | |
| SCHEMBL9750070 | 0.87 | SCN9A (0.39) | CTSSCTSKSCN9ARENCACNA1B | |
| SCHEMBL8893455 | 0.86 | CTSS (0.44) | CTSSCTSKSCN9ACTSLCTSB | |
| SCHEMBL9876609 | 0.85 | REN (0.44) | CTSSCTSKRENCYP3A4 | |
| SCHEMBL7425454 | 0.85 | CTSK (0.43) | CTSSCTSKRENCTSLCTSB | |
| SCHEMBL8894525 | 0.82 | CTSS (0.39) | CTSSCTSKSCN9ARENCTSL | |
| SCHEMBL7442988 | 0.82 | CTSS (0.39) | CTSSCTSKSCN9ARENCTSL | |
| SCHEMBL9750052 | 0.81 | CTSS (0.39) | CTSSCTSKRENCACNA1BCYP3A4 | |
| SCHEMBL9876362 | 0.81 | CTSS (0.41) | CTSSCTSKRENCTSBCACNA1B | |
| SCHEMBL10762000 | 0.81 | CTSS (0.41) | CTSSCTSKRENCTSBCACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5643878-A | TREATMENT OF RETROVIRAL DISEASES LIKE AIDS | CIBA-GEIGY CORPORATION (US) | 1997-07-01 | — | — | US | disclosed |